Decibel Therapeutics (DBTX) –
-
Form SC 13G/A Decibel Therapeutics, Filed by: CITADEL ADVISORS LLC
-
Form 15-12G Decibel Therapeutics,
-
Form EFFECT Decibel Therapeutics,
-
Form SC 13D/A Decibel Therapeutics, Filed by: REGENERON PHARMACEUTICALS, INC.
-
Form 4 Decibel Therapeutics, For: Sep 25 Filed by: Trask Anna
-
Form 4 Decibel Therapeutics, For: Sep 25 Filed by: Carson William H.
-
Form 4 Decibel Therapeutics, For: Sep 25 Filed by: FINGER ALISON CECILY
-
Form 4 Decibel Therapeutics, For: Sep 25 Filed by: Lee John Jui-Jen
-
Form 4 Decibel Therapeutics, For: Sep 25 Filed by: MCLAUGHLIN KEVIN F
-
Form 4 Decibel Therapeutics, For: Sep 25 Filed by: Reid Laurence
-
Form 4 Decibel Therapeutics, For: Sep 25 Filed by: Kapusta Matthew C
-
Form 4 Decibel Therapeutics, For: Sep 25 Filed by: Nochur Sara
-
Form S-8 POS Decibel Therapeutics,
-
Form S-8 POS Decibel Therapeutics,
-
Form S-8 POS Decibel Therapeutics,
-
Form POS AM Decibel Therapeutics,
-
Form 8-K Decibel Therapeutics, For: Sep 25
-
Form SC 14D9/A Decibel Therapeutics, Filed by: Decibel Therapeutics, Inc.
-
Form 25-NSE Decibel Therapeutics, Filed by: Nasdaq Stock Market LLC
-
Form SC TO-T/A Decibel Therapeutics, Filed by: REGENERON PHARMACEUTICALS, INC.
-
Form SC TO-T/A Decibel Therapeutics, Filed by: REGENERON PHARMACEUTICALS, INC.
-
Form SC 14D9/A Decibel Therapeutics, Filed by: Decibel Therapeutics, Inc.
-
Form SC 14D9/A Decibel Therapeutics, Filed by: Decibel Therapeutics, Inc.
-
Form SC TO-T/A Decibel Therapeutics, Filed by: REGENERON PHARMACEUTICALS, INC.
-
Moore Kuehn Encourages SOVO, DBTX, DM and ZYNE Investors to Contact Law Firm
-
Moore Kuehn Encourages CTG, KLR, ZYNE, and DBTX Investors to Contact Law Firm
-
Moore Kuehn Encourages AMED, DBTX, RETA, and SURF Investors to Contact Law Firm
-
Form SC 14D9 Decibel Therapeutics, Filed by: Decibel Therapeutics, Inc.
-
Form SC TO-T Decibel Therapeutics, Filed by: REGENERON PHARMACEUTICALS, INC.
-
Form 8-K Decibel Therapeutics, For: Aug 25
-
Moore Kuehn Encourages DBTX, AVID, CPRI, and ARCE Investors to Contact Law Firm
-
Form SC 13D Decibel Therapeutics, Filed by: REGENERON PHARMACEUTICALS, INC.
-
Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update
-
Form 10-Q Decibel Therapeutics, For: Jun 30
-
Baird Downgrades Decibel Therapeutics Inc (DBTX) to Neutral
-
Form SC14D9C Decibel Therapeutics, Filed by: Decibel Therapeutics, Inc.
-
Form SC TO-C Decibel Therapeutics, Filed by: REGENERON PHARMACEUTICALS, INC.
-
Jones Trading Downgrades Decibel Therapeutics Inc (DBTX) to Hold
-
DBTX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Decibel Therapeutics to Regeneron Pharmaceuticals
-
H.C. Wainwright Downgrades Decibel Therapeutics Inc (DBTX) to Neutral
-
DBTX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Decibel Therapeutics to Regeneron Pharmaceuticals
-
Form 8-K Decibel Therapeutics, For: Aug 08
-
Decibel Therapeutics (DBTX) to Resume Trading at 8 a.m.
-
Regeneron (REGN) to Acquire Decibel Therapeutics (DBTX) for Over $4 Per Share
-
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs
-
Decibel Therapeutics (DBTX) Halted, News Pending
-
Form 4 Decibel Therapeutics, For: Jun 13 Filed by: Nochur Sara
-
Form 4 Decibel Therapeutics, For: Jun 13 Filed by: Carson William H.
-
Form 4 Decibel Therapeutics, For: Jun 13 Filed by: FINGER ALISON CECILY
-
Form 4 Decibel Therapeutics, For: Jun 13 Filed by: MCLAUGHLIN KEVIN F
Back to DBTX Stock Lookup